Literature DB >> 20709096

The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.

Jane E Sutherland1, Linda C Burian, Jonathan Covault, Lisa H Conti.   

Abstract

Stress plays a role in many psychiatric disorders that are characterized by deficits in prepulse inhibition (PPI), a form of sensorimotor gating. Corticotropin-releasing factor (CRF) is one of the most important neurotransmitters involved in behavioral components of the stress response, and central infusion of CRF decreases PPI in rodents. We recently demonstrated that restraint stress decreases PPI and attenuates the increase in PPI caused by repeated testing. To broaden our investigation into how restraint affects PPI, we subjected Wistar-Kyoto (WKY) and Brown Norway (BN) rats to 10 consecutive days of 2-hour restraint, or to brief handling, prior to assessing PPI. We next examined the effects of 1 or 10days of 2-hour restraint on plasma corticosterone levels in order to determine whether the endocrine response to stress parallels the behavioral effect of stress. Finally, we examined the effects of 1 or 10days of 2-hour restraint on CRF and CRF receptor gene expression in the amygdala, hippocampus, frontal cortex, and hypothalamus in order to determine whether a temporal pattern of gene expression parallels the change in the behavioral response to stress. The major findings of the present study are that 1) restraint stress attenuates the increase in PPI caused by repeated testing in both WKY and BN rats, and BN rats are more sensitive to the effects of restraint on PPI than WKY rats, 2) restraint-induced increases in corticosterone levels mirror the effect of restraint on PPI in WKY rats but not in BN rats, 3) laterality effects on gene expression were observed for the amygdala, whereby restraint increases CRF gene expression in the left, but not right, amygdala, and 4) some restraint-induced changes in CRF and CRF receptor gene expression precede changes in PPI while other changes coincide with altered PPI in a rat strain- and brain region-dependent manner.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709096      PMCID: PMC2956775          DOI: 10.1016/j.pbb.2010.08.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  72 in total

1.  Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine.

Authors:  D L Martinez; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1997-03       Impact factor: 7.853

Review 2.  Ethology and neurobiology of grooming behavior.

Authors:  B M Spruijt; J A van Hooff; W H Gispen
Journal:  Physiol Rev       Date:  1992-07       Impact factor: 37.312

Review 3.  Stress, memory and the amygdala.

Authors:  Benno Roozendaal; Bruce S McEwen; Sumantra Chattarji
Journal:  Nat Rev Neurosci       Date:  2009-06       Impact factor: 34.870

4.  Radioimmunoassay data processing with a small programmable calculator.

Authors:  S E Davis; P J Munson; M L Jaffe; D Rodbard
Journal:  J Immunoassay       Date:  1980

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone.

Authors:  Anneloes Dirks; Lucianne Groenink; Marlies Iutje Schipholt; Jan van der Gugten; Theo H Hijzen; Mark A Geyer; Berend Olivier
Journal:  Biol Psychiatry       Date:  2002-04-01       Impact factor: 13.382

Review 7.  Schizophrenia: a neural diathesis-stress model.

Authors:  E F Walker; D Diforio
Journal:  Psychol Rev       Date:  1997-10       Impact factor: 8.934

8.  Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus.

Authors:  N H Kalin; L K Takahashi; F L Chen
Journal:  Brain Res       Date:  1994-09-05       Impact factor: 3.252

9.  Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.

Authors:  Z Merali; J McIntosh; P Kent; D Michaud; H Anisman
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

10.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

View more
  10 in total

1.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?

Authors:  Vaishali P Bakshi; Karen M Alsene; Patrick H Roseboom; Elenora E Connors
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

3.  Neurochemically distinct circuitry regulates locus coeruleus activity during female social stress depending on coping style.

Authors:  Beverly A S Reyes; Xiao-Yan Zhang; Elsa C Dufourt; Seema Bhatnagar; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2019-02-14       Impact factor: 3.270

4.  Effects of stress, acute alcohol treatment, or both on pre-pulse inhibition in high- and low-alcohol preferring mice.

Authors:  M S Powers; J A Chester
Journal:  Alcohol       Date:  2014-01-08       Impact factor: 2.405

5.  Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Authors:  Tariq W Chohan; Aurelie A Boucher; Jarrah R Spencer; Mustafa S Kassem; Areeg A Hamdi; Tim Karl; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold
Journal:  Schizophr Bull       Date:  2014-01-17       Impact factor: 9.306

6.  Roles of aldosterone and oxytocin in abnormalities caused by sevoflurane anesthesia in neonatal rats.

Authors:  Wengang Cao; Christopher Pavlinec; Nikolaus Gravenstein; Christoph N Seubert; Anatoly E Martynyuk
Journal:  Anesthesiology       Date:  2012-10       Impact factor: 7.892

7.  An allosteric modulator of metabotropic glutamate receptors (mGluR₂), (+)-TFMPIP, inhibits restraint stress-induced phasic glutamate release in rat prefrontal cortex.

Authors:  Erin R Hascup; Kevin N Hascup; Francois Pomerleau; Peter Huettl; Eva Hajos-Korcsok; Jan Kehr; Greg A Gerhardt
Journal:  J Neurochem       Date:  2012-06-13       Impact factor: 5.372

8.  Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Keizo Takao; Kazunori Nishi; Yasuaki Ito; Yoshitaka Yasuhara; Yasuhito Nakatomi; Chihiro Yokoyama; Kenji Fukui; Tsuyoshi Miyakawa; Masaki Tanaka
Journal:  Front Behav Neurosci       Date:  2011-08-17       Impact factor: 3.558

9.  Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex.

Authors:  Tariq W Chohan; An Nguyen; Stephanie M Todd; Maxwell R Bennett; Paul Callaghan; Jonathon C Arnold
Journal:  Front Behav Neurosci       Date:  2014-09-29       Impact factor: 3.558

10.  Clozapine prevented social interaction deficits and reduced c-Fos immunoreactivity expression in several brain areas of rats exposed to acute restraint stress.

Authors:  Rodolpho Pereira de Oliveira; José Simões de Andrade; Marianna Spina; João Vítor Chamon; Paulo Henrique Dias Silva; Ana Keyla Werder; Daniela Ortolani; Lucas de Santana Cardoso Thomaz; Simone Romariz; Daniel Araki Ribeiro; Beatriz Monteiro Longo; Regina Célia Spadari; Milena de Barros Viana; Liana Melo-Thomas; Isabel Cristina Céspedes; Regina Cláudia Barbosa da Silva
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.